Content Graph — Verification Intelligence for Your Complete Drug Lifecycle Small and mid-cap pharma lose capital, time, and programs to failures that could have been caught earlier. Non-viable candidates consume wet lab budgets. Unverified IND submissions attract Complete Response Letters. NDA narratives that cannot be defended against source data put years of investment at risk. The drag compounds at every stage. And the later it is caught, the more catastrophic the cost. Content Graph eliminates the drag. We deliver Big Pharma-grade verification across the complete drug development lifecycle, from first candidate to final NDA submission, at a price that fits an SMC pharma program budget. Our platform ingests outputs from any system: vHTS, LIMS, or AI, verifying candidate viability, IND accuracy, and NDA narrative integrity with forensic precision. We call this Data Integrity Protection™. Our founding team built Data Privacy, DLP, and Cloud Security infrastructure for regulated markets at Cisco. We are applying that same rigour in reverse, ensuring inaccurate data never infiltrates pharmaceutical intelligence. AI is advancing drug discovery. Verification ensures it accelerates in the right direction.
| Website | https://www.contentgraph.ai |
| Employees | 2 (2 on RocketReach) |
| Founded | 2025 |
| Industry | Technology, Information and Internet |
Looking for a particular Content Graph employee's phone or email?
Kevin Holmes is the Founder and CEO of Content Graph.
2 people are employed at Content Graph.
Content Graph is based in London, England.